Table 2.
Ginsenosides | Calibration curve equation | Correlation coefficient | Range (ng/mL) |
LOD (ng/mL) |
LOQ (ng/mL) |
Recovery % (RSD%) |
||
---|---|---|---|---|---|---|---|---|
100 ng/mL | 1,000 ng/mL | 2,000 ng/mL | ||||||
Re | y = 10.691x+ 2519.7 | R2 = 0.9973 | 50–5,000 | 7.51 | 24.99 | 104.4 (8.8) | 94.8 (6.6) | 116.5 (7.4) |
Rg1 | y = 13.074x + 7896.7 | R2 = 0.9930 | 50–5,000 | 4.52 | 15.06 | 104.2 (11.1) | 116.8 (10.1) | 104.2 (8.9) |
Rf | y = 9.7808x + 4535.2 | R2 = 0.9940 | 50–5,000 | 4.23 | 14.09 | 98.9 (8.9) | 98.2 (4.8) | 109.2 (9.4) |
Rb1 | y = 4.7875x + 360.18 | R2 = 0.9964 | 50–5,000 | 12.01 | 40.03 | 97.6 (10.0) | 101.9 (0.6) | 106.2 (2.6) |
Rc | y = 1.9243x + 520.16 | R2 = 0.9951 | 50–5,000 | 15.05 | 50.17 | 95.2 (7.3) | 95.1 (9.1) | 100.4 (4.5) |
Rb2 | y = 1.6348x + 545.69 | R2 = 0.9955 | 50–5,000 | 12.04 | 40.12 | 90.4 (5.0) | 80.1 (8.8) | 109.1 (8.7) |
Rd | y = 10.886x + 1745.9 | R2 = 0.9917 | 50–5,000 | 2.27 | 7.56 | 104.9 (6.9) | 101.7 (4.1) | 95.5 (3.9) |
Rg2 | y = 0.5688x + 389.94 | R2 = 0.9902 | 50–5,000 | 20.05 | 66.83 | 115.8 (9.6) | 94.5 (10.7) | 111.7 (7.7) |
Rh1 | y = 2.6693x + 170.07 | R2 = 0.9987 | 50–5,000 | 3.33 | 11.11 | 123.7 (9.5) | 107.7 (8.1) | 107.2 (2.2) |
F1 | y = 4.189 x + 1495.3 | R2 = 0.9905 | 50–5,000 | 9.38 | 31.25 | 96.1 (8.1) | 100.5 (0.4) | 95.9 (4.9) |
F2 | y = 11.384x + 4093.2 | R2 = 0.9910 | 50–5,000 | 2.64 | 8.79 | 104.9 (6.5) | 109.5 (11.5) | 107.2 (2.3) |
Rg3 | y = 11.374x + 3971.8 | R2 = 0.9916 | 50–5,000 | 13.63 | 45.43 | 112.0 (9.2) | 99.2 (10.1) | 105.2 (7.6) |
PPT | y = 5.7564x + 1116.6 | R2 = 0.9971 | 50–5,000 | 7.23 | 24.09 | 109.3 (4.8) | 86.5 (7.6) | 102.9 (0.9) |
Compound K | y = 6.5315x + 1551.7 | R2 = 0.9953 | 50–5,000 | 5.35 | 17.83 | 78.5 (8.2) | 101.4 (9.6) | 82.5 (8.8) |
Rh2 | y = 5.5618x + 1891.3 | R2 = 0.9978 | 50–5,000 | 4.68 | 13.59 | 82.0 (9.2) | 99.5 (8.7) | 113.7 (9.1) |